Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 5Unknown 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Breast Neoplasms 7Triple Negative Breast Neoplasms 2Neoplasm Metastasis 2Lung Neoplasms 2Carcinoma, Hepatocellular 2Osteosarcoma 1Lung Metastases 1Humoral Hypercalcemia Of Malignancy 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Bone Metastatic Non-small Cell Lung Cancer 1

Interventions

Cisplatin 38Carboplatin 28Gemcitabine 23Docetaxel 20Radiotherapy 18Etoposide 15Paclitaxel 13Erlotinib Hydrochloride 13Vinorelbine 11Drug Therapy 11pembrolizumab 9aumolertinib 9apatinib 9Pemetrexed 9Gefitinib 9osimertinib 7endostar protein 7Thoracic Surgery, Video-Assisted 7Blood Specimen Collection 7camrelizumab 6anlotinib 6Vinblastine 6Surgical Procedures, Operative 6sintilimab 5Radiosurgery 5Fluorodeoxyglucose F18 5Cyclophosphamide 5Bevacizumab 5durvalumab 4Mitomycin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Lung Neoplasms × Zoledronic Acid × Clear all
NCT02622607 2017-07-21

Preventive Effects of Zoledronic Acid on Bone Metastasis in Patients With Stage IIIB and IV Lung Cancer

Tang-Du Hospital

Phase 3 Unknown
200 enrolled
Thoracic

Lung Neoplasms

NCT01737216 2012-12-31

Pilot Study of Zoledronic Acid in Combination With First-line Chemotherapy in Aged Patients With Lung Cancer

Hebei Tumor Hospital

Phase 2 Unknown
100 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡